Visualization of early stage bladder cancer is considerably improved using Delta-Aminolevulinic acid (ALA) as tumor marking agent. This is due to an intracellular accumulation of fluorescing Protoporphyrin IX in tissue following intravesical installation of ALA in a pH-neutral solution.